Prognostic factors of 30-day mortality in patients with COVID-19 pneumonia under standard remdesivir and dexamethasone treatment

Although some studies have reported prognostic factors for coronavirus disease 2019 (COVID-19), they were conducted before standard treatment with remdesivir and dexamethasone was implemented. This retrospective, observational study was conducted to evaluate various prognostic factors in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yu Jung, Song, Joon Young, Hyun, Hakjun, Nham, Eliel, Yoon, Jin Gu, Seong, Hye, Noh, Ji Yun, Cheong, Hee Jin, Kim, Woo Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508954/
https://www.ncbi.nlm.nih.gov/pubmed/36197235
http://dx.doi.org/10.1097/MD.0000000000030474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508954/
https://www.ncbi.nlm.nih.gov/pubmed/36197235
http://dx.doi.org/10.1097/MD.0000000000030474

Ejemplares similares